Overview

An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice

Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
The objective of this survey on this registered product is to confirm the efficacy, and safety profile of Lantus in every day medical practice. This program will also help to obtain information about the use of the insulin titration regimen and handling of the Lantus insulin analogue.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Insulin Glargine